Comparation of Chidamide Plus VRD (Bortezomib, Lenalidomide, Dexamethasone) With VRD Regimen for Primary High-Risk Multiple Myeloma Patients
Clinical trial NCT04025450 · RECRUITING
Trial details
- NCT number
- NCT04025450
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-15
- Primary completion
- 2029-07-15
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.